Amgen sues state over price cap law
Drug maker Amgen, the maker of Enbrel, has sued the state because of the Prescription Drug Affordability Board decision to cap the price of the drug.
The Denver Post reported that the drug maker believes that the law permitting the price cap is unconstitutional and conflicts with federal law.
SPONSORED CONTENT
Drug maker Amgen has sued the state over a price cap placed on its Enbrel drug.